These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12022907)

  • 1. Pharmacology and clinical use of bivalirudin.
    Sciulli TM; Mauro VF
    Ann Pharmacother; 2002 Jun; 36(6):1028-41. PubMed ID: 12022907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bivalirudin: a direct thrombin inhibitor.
    Gladwell TD
    Clin Ther; 2002 Jan; 24(1):38-58. PubMed ID: 11833835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bivalirudin: a review of its potential place in the management of acute coronary syndromes.
    Carswell CI; Plosker GL
    Drugs; 2002; 62(5):841-70. PubMed ID: 11929334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacology of bivalirudin.
    Reed MD; Bell D
    Pharmacotherapy; 2002 Jun; 22(6 Pt 2):105S-111S. PubMed ID: 12064567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bivalirudin: pharmacology and clinical applications.
    Shammas NW
    Cardiovasc Drug Rev; 2005; 23(4):345-60. PubMed ID: 16614733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous coronary intervention in patients with acute coronary syndrome: focus on bivalirudin.
    Ramana RK; Lewis BE
    Vasc Health Risk Manag; 2008; 4(3):493-505. PubMed ID: 18827868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bivalirudin: an anticoagulant for acute coronary syndromes and coronary interventions.
    White HD; Chew DP
    Expert Opin Pharmacother; 2002 Jun; 3(6):777-88. PubMed ID: 12036417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bivalirudin: a new approach to anticoagulation.
    Nawarskas JJ; Anderson JR
    Heart Dis; 2001; 3(2):131-7. PubMed ID: 11975781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bivalirudin: a review of its use in patients undergoing percutaneous coronary intervention.
    Moen MD; Keating GM; Wellington K
    Drugs; 2005; 65(13):1869-91. PubMed ID: 16114983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bivalirudin, a bivalent, thrombin specific anticoagulant as an alternative to heparin in interventional procedures as an alternative to heparin in interventional procedures.
    Chew DP
    Hamostaseologie; 2002 Aug; 22(3):60-6. PubMed ID: 12215763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bivalirudin in percutaneous coronary intervention.
    Caron MF; McKendall GR
    Am J Health Syst Pharm; 2003 Sep; 60(18):1841-9. PubMed ID: 14521034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bivalirudin for patients with acute coronary syndromes.
    Stone GW; McLaurin BT; Cox DA; Bertrand ME; Lincoff AM; Moses JW; White HD; Pocock SJ; Ware JH; Feit F; Colombo A; Aylward PE; Cequier AR; Darius H; Desmet W; Ebrahimi R; Hamon M; Rasmussen LH; Rupprecht HJ; Hoekstra J; Mehran R; Ohman EM;
    N Engl J Med; 2006 Nov; 355(21):2203-16. PubMed ID: 17124018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bivalirudin during primary PCI in acute myocardial infarction.
    Stone GW; Witzenbichler B; Guagliumi G; Peruga JZ; Brodie BR; Dudek D; Kornowski R; Hartmann F; Gersh BJ; Pocock SJ; Dangas G; Wong SC; Kirtane AJ; Parise H; Mehran R;
    N Engl J Med; 2008 May; 358(21):2218-30. PubMed ID: 18499566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bivalirudin: a direct thrombin inhibitor in percutaneous coronary interventions].
    Hansen PR
    Ugeskr Laeger; 2006 Sep; 168(38):3207-9. PubMed ID: 17026893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct antithrombins: mechanisms, trials, and role in contemporary interventional medicine.
    Wong CK; White HD
    Am J Cardiovasc Drugs; 2007; 7(4):249-57. PubMed ID: 17696566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of bivalirudin versus heparins in reduction of cardiac outcomes in acute coronary syndrome and percutaneous coronary interventions.
    Singh S; Molnar J; Arora R
    J Cardiovasc Pharmacol Ther; 2007 Dec; 12(4):283-91. PubMed ID: 18172222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized comparison of bivalirudin and heparin in patients undergoing coronary angioplasty for postinfarction angina. Hirulog Angioplasty Study Investigators.
    Bittl JA; Feit F
    Am J Cardiol; 1998 Oct; 82(8B):43P-49P. PubMed ID: 9809891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale.
    Stone GW; Bertrand M; Colombo A; Dangas G; Farkouh ME; Feit F; Lansky AJ; Lincoff AM; Mehran R; Moses JW; Ohman M; White HD
    Am Heart J; 2004 Nov; 148(5):764-75. PubMed ID: 15523305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. Hirulog Angioplasty Study Investigators.
    Bittl JA; Strony J; Brinker JA; Ahmed WH; Meckel CR; Chaitman BR; Maraganore J; Deutsch E; Adelman B
    N Engl J Med; 1995 Sep; 333(12):764-9. PubMed ID: 7643883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bleeding risk and outcomes of Bivalirudin versus Glycoprotein IIb/IIIa inhibitors with targeted low-dose unfractionated Heparin in patients having percutaneous coronary intervention for either stable or unstable angina pectoris.
    Steinberg DH; Shah P; Kinnaird T; Pinto Slottow TL; Roy PK; Okabe T; Bonello L; de Labriolle A; Smith KA; Torguson R; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2008 Jul; 102(2):160-4. PubMed ID: 18602514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.